Loading clinical trials...
Loading clinical trials...
This is a double- blind, randomized controlled trial with an open label extension designed to evaluate the safety and potential efficacy of a non-invasive brainstem neuromodulation device for treating...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Scion NeuroStim
NCT05417555 · Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, and more
NCT06058234 · Mild Alzheimer's Disease, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
NCT03186989 · Mild Alzheimer's Disease
NCT01482013 · Mild Alzheimer's Disease, Mild Cognitive Impairment
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
USF Health Byrd Alzheimer's Institute
Tampa, Florida
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions